You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Lectin-like oxidized LDL receptor (LOX-1)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Endometriosis Trial in University Park (Salsalate Pill, Placebo)

Recruiting
  • Endometriosis
  • Salsalate Pill
  • Placebo
  • University Park, Pennsylvania
    The Pennsylvania State University
Dec 13, 2022

Endometriosis Trial in University Park (Atorvastatin)

Recruiting
  • Endometriosis
  • University Park, Pennsylvania
    The Pennsylvania State University
Apr 8, 2022

Endometriosis Trial in New Haven (simvastatin 10mg, Bazedoxifene 20/Estrogens,Con 0.45Mg Tb, Placebo)

Recruiting
  • Endometriosis
  • simvastatin 10mg
  • +2 more
  • New Haven, Connecticut
    The John B. Pierce Laboratory
Dec 8, 2022

Acute Coronary Syndrome Trial in Baltimore (Evolocumab, Placebo)

Active, not recruiting
  • Acute Coronary Syndrome
  • Baltimore, Maryland
    Steven Paul Schulman
Jan 19, 2022

Oxidized Low Density Lipoprotein Trial in Fort Lauderdale (Cardio formulation, Placebo)

Terminated
  • Oxidized Low Density Lipoprotein
  • Cardio formulation
  • Placebo
  • Fort Lauderdale, Florida
    Lfie Extension Clinical Reseach, Inc.
Jan 12, 2023

Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory Trial (CB-012)

Not yet recruiting
  • Acute Myeloid Leukemia, in Relapse
  • Acute Myeloid Leukemia Refractory
  • (no location specified)
Nov 9, 2023

Diabetes, Type 2, Dyslipidemia Associated With Type II Diabetes, Percutaneous Coronary Intervention Trial in Falls Church

Terminated
Has Results
  • Diabetes Mellitus, Type 2
  • +2 more
  • Falls Church, Virginia
    Inova Fairfax Hospital
Dec 22, 2022

Glucagon-like Peptide-1 Receptor Agonists According to Type 2

Recruiting
  • Diabetes Mellitus, Type 2
  • GLP-1 receptor agonist
  • Bari, Italy
    Azienda Ospedaliero-Universitaria Policlinico Bari
Nov 4, 2023

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Philadelphia (OC-L/Montanide ISA 51 VG, Ampligen,

Terminated
Has Results
  • Ovarian Cancer
  • +2 more
  • OC-L/Montanide ISA 51 VG
  • +2 more
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Oct 18, 2021

Oxidized LDL With Oxygen Therapy in Acute Coronary Syndrome.

Unknown status
  • Acute Coronary Syndrome
  • Oxidized-LDL gene polymorphism
  • (no location specified)
Feb 4, 2019

sCLEC-2 in Stroke Study

Not yet recruiting
  • Acute Ischemic Stroke
  • Transient Ischemic Attack
    • Katori, Chiba, Japan
    • +8 more
    Oct 10, 2022

    SLE Trial (Blood test)

    Not yet recruiting
    • SLE
    • Blood test
    • (no location specified)
    Jul 27, 2022

    Hypercholesterolemia Trial in Clermont-ferrand, Clermont-Ferrand, Durtol (LIMICOL, PLACEBO)

    Completed
    • Hypercholesterolemia
    • LIMICOL
    • PLACEBO
    • Clermont-ferrand, France
    • +3 more
    Feb 28, 2023

    Familial Adenomatous Polyposis Trial in Houston (Celecoxib, Colonoscopy Biopsy)

    Completed
    • Familial Adenomatous Polyposis
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Mar 10, 2022

    LDL-Apheresis for FSGS CardioRenal Outcomes

    Enrolling by invitation
    • Focal Segmental Glomerulosclerosis
    • No intervention
    • Cincinnati, Ohio
    • +1 more
    Jan 25, 2023

    Polycystic Ovary Syndrome Trial in Shanghai (GLP-1 RAs, calorie restricted diet)

    Completed
    • Polycystic Ovary Syndrome
    • GLP-1 RAs
    • calorie restricted diet
    • Shanghai, Shanghai, China
      Shanghai Tenth People' Hospital
    Aug 2, 2022

    Squamous Cell Carcinoma of Head and Neck Trial in Newark, Stratford (MASL, Placebo)

    Recruiting
    • Squamous Cell Carcinoma of Head and Neck
    • Newark, New Jersey
    • +3 more
    Apr 26, 2022

    GLP-1RAs) and SGLT2is Combination Therapy and MACEs in Type 2

    Recruiting
    • Diabetes Mellitus, Type 2
    • Myocardial Infarction
    • PCI
    • Naples, Italy
      Celestino Sardu
    Aug 31, 2023

    Endocrine Neoplasia Trial in Houston (4-[18F]Fluoro-1-Naphthol)

    Recruiting
    • Endocrine Neoplasia
    • Houston, Texas
      MD Anderson Cancer Center
    Nov 16, 2022

    Type 2 Diabetes, Diabetes, Type 2 Trial (Tirzepatide)

    Not yet recruiting
    • Type 2 Diabetes
    • Diabetes Mellitus, Type 2
    • (no location specified)
    Feb 6, 2023

    PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries, Obese Trial (Semaglutide)

    Not yet recruiting
    • PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries
    • Obese
    • (no location specified)
    Apr 6, 2023

    Caveolin 1 Deficiency in Response to Glucagon-like Peptide 1

    Not yet recruiting
    • Overweight and Obesity
    • 24-hour ambulatory blood pressure
    • Liberal salt diet
    • (no location specified)
    Oct 4, 2023

    Coronary Artery Disease, Dyslipidemias Trial in Yongin (a high dose of statin/ezetimib)

    Recruiting
    • Coronary Artery Disease
    • Dyslipidemias
    • a high dose of statin/ezetimib
    • Yongin, Gyeonggi-do, Korea, Republic of
      Yongin Severance Hospital
    Jun 14, 2023

    Lipids, Lipid Metabolism, Healthy Trial in Reading, Guildford (High SFA diet (Diet 1), Low SFA diet (Diet 2))

    Completed
    • Lipids
    • +2 more
    • High SFA diet (Diet 1)
    • Low SFA diet (Diet 2)
    • Reading, Berkshire, United Kingdom
    • +1 more
    Oct 15, 2021

    Osteoporosis, Postmenopausal, Diabetes, Type 2 Trial in Jackson (GLP-1 receptor agonist)

    Recruiting
    • Osteoporosis, Postmenopausal
    • Diabetes Mellitus, Type 2
    • GLP-1 receptor agonist
    • Jackson, Mississippi
      University of Mississippi Medical Center
    Aug 5, 2022